LONG: $APHADaily Time Frame:
- Breakout
- Ongoing Wave C of 4
- EMA20 and EMA50 would be crossing each other soon
Monthly Time Frame:
- Ongoing Wave 4 (pump)
- I am expecting another drop after the stock reaches ~$5
Cannabis
[ACB] Pump and Dump... It's Gonna Collapse AgainFOMO got the best of of the market again. Was a beautiful setup. I loaded up on ACB the 5 days leading up to earnings because it was beautifully positioned at insane value and because almost any shred of good news was almost sure to make this stock pop.
Bought @$6.22, sold ~20% @$10.62 yesterday and another ~20% @ $18.56 today.
Will sell another ~20% if it spikes higher again but it was almost surely being pumped a lot extra from the rally and I expect it to collapse back down, maybe bounce at ~$13 and then return to test lows before next earnings.
The impending market crash will make all cannabis stocks the buys of a century (especially OGI) for a brief couple days. 2021 will see explosive growth and massive gains for all of them.
[CGC] Get in Now to Ride the FOMO Earnings WaveCGC is a much higher quality company with much better fundamentals than ACB, which just popped 200% on earnings last week. CGC is better priced than ACB already though so if earnings show any life at all, I'm expecting more along the lines of a 50-100% increase maxing out around $26. Great sell starting at $22 for an earnings swing trade.
If earnings are particularly bad we may retest lows before next earnings but probably won't ever get below $10 again. I suspect investors (i.e. the FOMO crowd) will take any shred of good news as a huge bull signal and pile in before overall market weakness collapses the stock, same like ACB. Industry gravity is high, market gravity is high.
Anything around the POC (white line) is pretty solid value here and is where I'm looking to load up on more, expecting some retrace as the ACB cannabis industry bounce fades and the overall market slows heading toward earnings.
[TLRY] Boxed in w/ Nowhere to Go but Down, Load Up Pre EarningsBest case scenario TLRY bounces between $7 and $10 until earnings. I think it'll crack below the support there along with overall market weakness and tumble back down, who knows how low, really doubt it'll retest lows ($2.5 is a crazy steal) but anything under $7 really is a great value buy here especially after what ACB just demonstrated but if you're stingy like me you're probably aiming to buy in the $4-$5 range.
The industry gravity seems to be having an especially depressing effect on TLRY (aside from the overall climbing support line). Even as ACB soared and CGC, OGI, APHA and hell even the black sheep of the industry, SNDL and HEXO, made double digit gains, TLRY stayed mostly put.
Everything now reverting to mean because industry gravity is too high, that's only going to pull TLRY lower.
Eventually that gravity will dissipate and all these companies will soar, just a matter if that happens this earnings or next, but will happen.
ACB is rejecting from $19 level of resistanceIndeed, the market shares of Aurora cannabis in recent days blew very strongly from the point of view of volatility, the ATR indicator has jumped up from zero very fast. The stock has grown in value. But to judge this chart from the point of view of the interaction dynamics of price and volume is difficult because the market is too "noisy" and specific. Nevertheless, we will try to do the analysis.
Technically, the stock is in an uptrend which is marked by the orange lines. While the price is above the 50% Fibonacci at above $12 level, we need to consider this action from the perspective of bulls.
Level $12 per share is also very strong because we have a large bulb on the right side of the chart, in the market profile indicator. Also in favor of the bulls, there is the fact that the price is trading within the current orange channel.
Everything speaks in favor of growth. However, I'm confused about some facts in the area of $ 19.
The first fact - a narrow spread on large volume closing near the middle and the subsequent deep pullback from the overbought area is a clear sign of weakness (EVRT).
Number two, I outlined SLKT - it's tiny exceeding the previous maximum, which has a manipulative character.
Number 3 was a widespread down bar on high volume. I would have interpreted it as a Bar of Supply (SB).
Thus the signals form the sequence 123, which often could be found on top of the markets. With confidence, I can say that the area of 18-19 dollars per share acts as a powerful resistance.
As you can see, the signals are controversial. Given the weak opening of today's session, I would have preferred the game on the bearish side, because it is the most recent message from the chart. As long as the price will trade lower than $ 19 per share, the uptrend is under threat.
We are at a turning point TORONTO, May 19, 2020 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD) (US:TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it has signed a supply agreement with Medical Cannabis by Shoppers™ ("Shoppers"), a subsidiary of Shoppers Drug Mart Inc., making their certified organic medical cannabis products available via the Shoppers online medical cannabis sales platform.
"We're thrilled to partner with Canada's largest pharmacy network, bringing together TGOD's unique expertise in developing high-quality certified organic cannabis products and Shoppers' unmatched national reach," commented Robert Gora, Vice President of Sales at TGOD. "We share their vision of facilitating access to medical cannabis for patients across Canada," added Gora.
Under the terms of the agreement, TGOD will provide Shoppers with a broad portfolio of certified organic medical cannabis products, including its latest 2.0 offering such as Infusers (dissolvable powder), teas and vapes. The agreement is for a three-year term with a renewal clause for an additional two year
[$ACB] Marijuana stocks are Strong !FR/EN
Tous les majors des producteurs de cannabis thérapeutiques enregistrent de forts gains, pour autant, $ACB annonce de très bonnes nouvelles, et cela plait fortement aux investisseurs :
- Croissance plus haute que prévue du revenu (+35% de hausse ce trimestre - 75 Millions $ Canadien en Q1)
- Production du cannabis thérapeutique parmi l'un des moins cher du marché , 4,33 $ Canadien et ACB continue d'innover pour fournir un produit de qualité à moindre coût.
- la légalisation du Cannabis se démocratise aux Etats Unis - 11 états + Washington D.C ont légalisé le cannabis récréatif + la légalisation totale au Canada depuis Octobre 2018.
--
All of the major therapeutic cannabis producers are making strong gains, yet $ACB is announcing some very good news, and this is very pleasing to investors:
- Higher than expected revenue growth (+35% increase this quarter - C$75 million in Q1).
- Producing one of the cheapest therapeutic cannabis on the market, $4.33 Canadian and ACB continues to innovate to provide a quality product at a lower cost.
- Cannabis legalization is democratizing in the United States - 11 states + Washington D.C. have legalized recreational cannabis + total legalization in Canada since October 2018.
Translated with www.DeepL.com (free version)
HEXO BUY (HEXO CORP)Hi there. Price is forming a reversal pattern to change its direction. Watch strong price action at the current price for buy.
OGI - Will Continue Downward Trend, Load Up Before Q2 EarningsOGI is one of the most undervalued stocks in the market and the best value Cannabis stock now that ACB has popped.
Anytime is good to buy before Q2 Earnings but it'll likely approach $1 again and then pop on earnings. Probably to similar degree as we just saw with ACB.
ACB About To Go ShortWe have seen an unprecedented rise in NYSE:ACB in the past days (216% since Thursday 5/14). This made the stock be close to the higher limit of top analysts targets. If we take a closer look into the ACB's fundamentals and financial conditions, we expect the stock to go short in the next months. There is low support for such a high rise at the moment, as the stock is at highest levels since February, on the other side there are signs the current valuation is over the realistic financial conditions.
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp-related food products.
$CGC -Canna getta Covid hit? NYSE:CGC
1. NYSE:ACB is up 89% in 2 days, after they reported for the Quanrentine Qtr.
2. CGC reports on 5/28. It’s not that crazy to think that CGC possibly will follow suite.
i’ve got a target range btwn $28 -$36
ACB BUY (AURORA CANNABIS INC)Hi there. Price is forming a big reversal pattern to change its direction. Also is close to 0 value which is a very good sign because is almost impossible that price go to negative values.
Watch strong price action at the current price for buy.
Swing Trade - Pot Stock - Stores Are ClosedCannabis dispensaries are closed, because there is a pandemic, so we have to sell our pot stocks. It's also getting denied at significant levels, i.e. $3.6 $4.4. Check out MACD, Oscillator, and RSI on daily:
Enjoy!
KHRNF - minute wve 3 up, possibility of gains Khiron Life Sciences seems to be tracing minute wave 3 up, after the end of an intermediate C down. If this is the case, wave 3 could reach the most probable target at 0.72, with more than 40% of gains. This scenario should be void if prices crosses down 0.34. Keep tuned. FOLLOW SKYLINEPRO TO GET UPDATES.
LEAF - Boston Globe News - Feds Lawsuit - Short? Thoughts?Hard to short sell here, but as of 30 minutes ago.. Let me know the impacts/your thoughts? Looks like news hasn't hit major stock news outlets yet.
Post comments.
About stock: www.marketwatch.com
www.ftc.gov
www.bostonglobe.com
Cannabis Looking Strong. (MJ)Last post on MJ Alternative Harvest we started we were opening longs @ $11.90
Currently sitting up 5%
We took this position based off the large timeframes, the weekly and 2 week.
Now you see a breakout with a settlement back on old Resistance to test as support.
Key is to play this as support. If it shifted right and than turned to break support back below the pattern upward support. We would than look for possible Retracement.
I'll stay put with my position for now.
This could be a really good time to diversify into the cannabis sector.
Enjoy, hope she keeps trucking!
Will keep you updated
CGC - opportunity for short-term gainsCGC is tracing a minute wave c up that should complete minor wave 4. The probable target is at around 23.00. FOLLOW SKYLINEPRO TO GET UPDATES.
$TLRY: $10 Short Potential [Currently < than IPO Price]First off, please don't take anything I say seriously, or as financial advice. That being said, let me get into a few of my key insights. Tilray is currently only $8.05 which is lower then the $17 price it was entry into the market. The stock peaked at $240 before starting to tumble down bearishly entering into 2019. Cannabis was a fad or bubble waiting to be popped. That being said, as a 750+ employee company that is revamping, it isn't a bad stock pick and may be a steal at its current price. Many analyst are neural on it, but I think it has light in the tunnel for growth. Today it had a high of $9.75, before going down to $8.05. Overall, day over day, the stock's close price went down -0.74%. Today was a notoriously bad day for the market, and this performance was better than expected. Overall, a short of $10 is reasonable, and this is one of those stocks that can likely be flipped multiple times for a day trader or trading bot. It seems to also have long potential, and I believe it will likely reach another bullish run.